Zhen Wang

24PUBLICATIONS
58CO-AUTHORS
Tissue engineeringReaction engineering (excl. nuclear reactions)Predictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 23, 2026
Development of DCL1191 as a Potent, Selective and Orally Bioavailable Inhibitor for Autophagy-Associated Transcription Factor EB (TFEB).

|Oct 23, 2026
Single-Atom Modification Enables Reversal of Degradation Selectivity between NSD2 and GSPT1.

|Jul 07, 2026
A ligandable PNT domain establishes ERG as a directly targetable oncogenic driver in prostate cancer.

|Jun 08, 2026
Structure-Based Design and Optimization of Novel, Potent and Selective Covalent FGFR2/3 Inhibitors with a Tricyclic Core.

|May 29, 2026
Discovery of a Potent, Selective and In Vivo Active Aurora A PROTAC Degrader from a Promiscuous Kinase Inhibitor.

|Mar 19, 2026
Structure-Based Design of Potent and Highly Selective NUAK1 Inhibitors by Exploiting a Unique Glutamate Switch for the Prevention of Tumor Growth, Migration, and Invasion.

Shan Li, Yingao Wang, Xuechen Liu

Pageof 4

Frequent Collaborators

20 joint publications

Ke Ding

9 joint publications

Fengtao Zhou

8 joint publications

Yang Zhou

5 joint publications

Weixue Huang